SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-19-000027
Filing Date
2019-02-13
Accepted
2019-02-13 17:17:11
Documents
26
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 sangui10q_20181231_audit_201.htm 10-Q 380446
2 sangui10q20181231audit2012.gif GRAPHIC 26956
3 exhibit31.01vedgar1.htm EX-31 7983
4 exhibit31.02vedgar1.htm EX-31 8540
5 exhibit32.01vedgar1.htm EX-32 4336
  Complete submission text file 0001551163-19-000027.txt   929305

Data Files

Seq Description Document Type Size
6 sgbi-20181231.xml EX-101.INS 57143
7 sgbi-20181231.xsd EX-101.SCH 6760
8 sgbi-20181231_cal.xml EX-101.CAL 14526
9 sgbi-20181231_def.xml EX-101.DEF 4698
10 sgbi-20181231_lab.xml EX-101.LAB 61538
11 sgbi-20181231_pre.xml EX-101.PRE 45385
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 19598668
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1